Kidron Capital is a seed to Series A venture capital firm deploying capital across medical devices, diagnostics, therapeutics, digital health, and health services. They invest in early-stage technologies improving the lives of female patients across conditions unique to women, predominant in women, or presenting differently in women, including cardiovascular, autoimmune, bone, cognitive, and oncology indications. The firm differentiates itself as the only women's health fund investing across therapeutic areas, modalities, and three geographies simultaneously, anchored in the Israeli healthcare innovation ecosystem.